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Abstract We evaluated the role of protein tyrosine phosphoryl- 
ation in amylase exocytosis from parotid acinar cells by using 
genistein, a tyrosine kinase inhibitor. Amylase release stimulated 
by isoproterenol was dose-dependently inhibited by genistein. 
Genistein also inhibited the exocytosis evoked by dibutyryl- or 
8-chlorophenylthio-cAMP. Daidzein, a negative control agent of 
genistein, elicited no inhibitory effect. Isoproterenol had dual 
effects on protein tyrosine phosphorylation; it increased the phos- 
phorylation of 190- and 210-kDa proteins and decreased that of 
a 90-kDa one. The phosphorylation was dose-dependently inhib- 
ited by genistein but not by daidzein. These results suggest hat 
protein tyrosine phosphorylation plays a role in the process of 
amylase exocytosis from parotid acinar cells. 
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1. Introduction 
Amylase release from parotid acinar cells is a typical model 
of cAMP-mediated exocytosis [1]. We recently demonstrated 
that the catalytic subunit of cAMP-dependent protein kinase 
induces amylase release from streptolysin O-permeabilized pa- 
rotid acinar cells [2]. In contrast, Ca2+-mobilizing agonists uch 
as cholecystokinin and acetylcholine mainly stimulate amylase 
release from pancreatic acini, and Ca and protein kinase C seem 
to be equally important in the regulatory mechanism [3]. How- 
ever, it was recently found that cholecystokinin and carbachol 
increased protein tyrosine phosphorylation in addition to 
serine/threonine phosphorylation and that tyrosine kinase in- 
hibitors, including genistein, significantly inhibited amylase re- 
lease stimulated by those agonists [4-7]. These results suggest 
that tyrosine kinases are involved in the regulation of amylase 
exocytosis from pancreatic acini. Since little is known concern- 
ing the role of tyrosine kinases in parotid acini, we studied the 
effect of genistein on amylase release and tyrosine phosphoryl- 
ation. The results obtained showed that isoproterenol-induced 
amylase release and protein tyrosine phosphorylation were 
dose-dependently inhibited by genistein but not by daidzein. 
2. Experimental 
2.1. Materials 
Genistein and daidzein were purchased from Extrasynthese (Genay, 
France). Monoclonal anti-phosphotyrosine a tibody and agarose-con- 
jugated monoclonal anti-phosphotyrosine a tibody (clone 4G10) were 
obtained from Upstate Biotechnology Inc. (Lake Placid, NY). Pefabloc 
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SC was from Merck (Darmstadt, Germany). Polyvinylidene difluoride 
(PVDF) membranes (Immobilon) were from Millipore (Bedford, MA). 
Enhanced chemiluminescence (ECL) kit was from Amersham (Little 
Chalfont, England). Isoproterenol, carbachol, leupeptin, orthovana- 
date, and Nonidet P-40 were from Sigma (St. Louis, MO). 8-Chloro- 
phenylthio-cAMP was from Boehringer Mannheim (Tokyo, Japan). 
All other chemicals utilized were the highest grade commercially avail- 
able. 
2.2. Preparation of parotid acini 
Rat parotid acini (small acini) were prepared as described previously 
[8]. In each experiment, parotid glands from one rat were minced finely 
and incubated with trypsin (0.5 mg/ml) for 10 min at 37°C in minimum 
essential medium (MEM) buffered with 20 mM Na-Hepes (pH 7.4: 
MEM-H) containing 0.1% bovine serum albumin (BSA) under 100% 
Oz in a metabolic shaker. The tissue was washed once with Ca 2+- and 
Mg2+-free Hanks' balanced salt solution containing 2 mM EGTA and 
then incubated for 5 min with trypsin inhibitor (0.5 mg/ml) in the same 
medium. After the tissue had been washed once with MEM-H, it was 
further incubated for 20 min in MEM-H containing collagenase (130 
U/ml), hyaluronidase (0.25 mg/ml), and 0.1% BSA. After digestion, 
dispersed acini were filtered through two layers of medical gauze, 
washed 4 times with MEM-H, and suspended in the same medium. 
2.3. Amylase release 
A suspension of parotid acini (1 ml) was pipetted into a 1.5-ml 
microcentrifuge tube containing 10 ,ul genistein or dimethylsulfoxide 
(DMSO) and preincubated at37°C for 20 min. The acini were further 
incubated with various agonists for 20 min. After incubation the tube 
was mixed and centrifuged at 10,000 rpm for 1 min at room tempera- 
ture, and the medium was used for assay of amylase released. For 
measurement of total amylase activity, acini were incubated with 0.2% 
Nonidet P-40 as above. Amylase activity was measured by the method 
of Bernfeld [9], and the released amylase activity was given as the 
percentage of the total activity. 
2.4. Tyrosine phosphorylation 
Parotid acini were preincubated for 20 min with genistein and further 
incubated for 5 min with various agonists. After incubation, the acini 
were pelleted and lysed with lysis buffer containing 40 mM Hepes-Na 
(pH 7.4), 140 mM NaC1, 1% Nonidet P-40, 2 mM EDTA, 1 mM sodium 
orthovanadate, 0.2 mM pefabloc SC, and 10 #g/ml leupeptin. The 
lysate was centrifuged at 15,000 rpm at 4°C for 5 min in a microcentri- 
fuge, and the resulting supernatant was then used for immunoprecipita- 
tion and immunoblotting. 
Phosphotyrosine-containing proteins were immunoprecipitated with 
agarose-conjugated monoclonal anti-phosphotyrosine antibody. The 
agarose beads were washed 5 times with lysis buffer, suspended in 
Laemmli buffer [10], and boiled for 5 min. The proteins were resolved 
by SDS-PAGE on 7.5% gels and then transferred to a PVDF membrane 
at 100 mA per mini-gel (90 × 73 × 1 mm) for 100 min in a semi-dry 
blotter using 0.1 M Tris~3.192 M glycine buffer containing 5% metha- 
nol. Phosphoproteins were visualized by immunoblotting with the same 
monoclonal antibody and the ECL system. 
3. Results 
3.1. Effects of genistein and daidzein on amylase release 
To evaluate the role of tyrosine kinases in amylase release, 
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Fig. 1. Effect of genistein on amylase release from parotid acini stimu- 
lated by various agonists. The acini were preincubated with 370/aM 
(100/ag/ml) genistein or 1% dimethylsulfoxide (DMSO) at 37°C for 20 
min, and further incubated for 20 min after addition of 1 yM isoproter- 
enol, 10/aM carbachol, or 100/aM sodium orthovanadate. Data shown 
are means + S.D. (n = 3) of a representative experiment of two inde- 
pendent experiments. 
we examined the effects of genistein on amylase release stimu- 
lated by isoproterenol, carbachol, or orthovanadate. As seen 
in Fig. 1, genistein markedly inhibited amylase release stimu- 
lated by isoproterenol. Effects of genistein on the action of 
other agonists were difficult to detect, since the magnitude of 
amylase release by those agonists was too small. 
The inhibitory effect ofgenistein on isoproterenol-stimulated 
exocytosis was dose dependent up to 300 pM; the maximum 
inhibition was approximately 80% at 300/,tM and the ICs0 value 
was approximately 120 pM (Fig. 2A). To confirm the effect of 
genistein isdue to inhibition oftyrosin kinase activity, we exam- 
ined the effect of daidzein, a compound closely related to gen- 
istein but without any inhibitory effect on tyrosine kinase activ- 
ity [11]. As seen in Fig. 2B, daidzein had no inhibitory effect. 
Genistein also inhibited amylase release stimulated by dibu- 
tyryl-cAMP (db-cAMP) and 8-chlorophenylthio-cAMP (cps- 
cAMP) (Fig. 3). In these experiments, daidzein slightly en- 
hanced amylase release stimulated by cAMP analogs. 
3.2. EJJects of isoproterenol and genistein on tyrosine 
phosphorylation 
To evaluate the role of protein tyrosine phosphorylation in 
amylase exocytosis, we studied the effects of various secre- 
tagogs and genistein on tyrosine phosphorylation levels in pa- 
rotid acini. Tyrosine-phosphorylated proteins in the lysate of 
parotid acini were immunoprecipitated, r solved on 7.5% poly- 
acrylamide gels, and visualized by immunoblotting. As seen in 
Fig. 4 (left), isoproterenol had dual effects on tyrosine phospho- 
rylation; it increased phosphorylation f two protein bands. 
whose molecular masses were apparently 190 and 210 (p190 
and p120, respectively, indicated by small arrows), and it de- 
creased the phosphorylation f a 90-kDa protein (p90, indi- 
cated by the arrowhead). Carbachol also decreased the phos- 
phorylation of p90 but markedly increased that of a 80-kDa 
protein (p80) instead of p190 or p210. The p80 was very likely 
to be protein kinase Ca as reported recently [12]. 
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To identify the intracellular second messengers that pro- 
duced those changes in protein tyrosine phosphorylation, we 
incubated parotid acini with 1 mM 8-chlorophenylthio-cAMP 
(cps-cAMP), 1/IM phorbol 12-myristate 13-acetate (PMA), or 
1 pM A23187 for 5 min, and tyrosine-phosphorylated proteins 
were analyzed as above. As seen in Fig. 4 (right), cps-cAMP 
completely mimicked the dual effects of isoproterenol, indicat- 
ing that those changes are cAMP-dependent events. On the 
other hand, PMA and A23187 mimicked either one of the two 
effects of carbachol; PMA enhanced the phosphorylation f 
pS0 and A23187 decreased that of p90. 
Genistein dose-dependently inhibited tryosine phosphoryla- 
tion in the parotid acini (Fig. 5). As expected, daidzein (300 
pM) scarcely inhibited tyrosine phosphorylation. 
4. Discussion 
The present study clearly shows that genistein dose-depen- 
dently inhibited amylase release and protein tyrosine phospho- 
rylation in parotid acini stimulated by isoproterenol. The mag- 
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Fig. 2. Effects of genistein and daidzein on amylase r lease from parotid 
acini stimulated by isoproterenol. The acini were preincubated with 
various concentrations of genistein (A) or daidzein (B) at 37°C for 20 
min, and further incubated for 20 min after addition of 1/aM isoproter- 
enol. Data shown are means + S.D. (n = 3) of a representative experi- 
ment of 3 independent experiments. 
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Fig. 3. Effects of genistein and daidzein on amylase release from parotid 
acini stimulated by membrane-permeable cAMP analogs. The acini 
were preincubated with 300/2M genistein, 300/.tM daidzein, or 1% 
DMSO at 37°C for 20 rain, and further incubated for 20 min after 
addition of 2 mM dibutyryl-cAMP or 1 mM cps-cAMP. Data shown 
are means _+ S.D. (n = 3) of a representative experiment of3 independ- 
ent experiments. 
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Fig. 4. Effects of various ecretagogs onprotein tyrosine phosphoryla- 
tion in parotid acini. Acini were incubated for 5 min with 1/2M iso- 
proterenol (ISO) or 10/IM carbachol (CCH) (the left panel) or 1 mM 
cps-cAMP (CPS-A), 1 /2M PMA, or 1/2M A23187 (A321) (the right 
panel). After incubation, phosphotyrosine containing proteins were 
immunoprecipitated by agarose-conjugated monoclonal anti- 
phosphotyrosine antibody and visualized by immunoblotting asde- 
scribed in section 2. The small arrows indicate 190- and 210-kDa pro- 
tein. The arrowhead and large arrow indicate 90- and 80-kDa proteins, 
respectively. CONT, control. The results hown are from two experi- 
ments representative of 4 independent experiments. 
nitude of the two inhibitory effects seems to be fairly well 
correlated. The IC50 value of 120/2M for amylase release agrees 
well with the value reported for Ca-induced amylase release 
from pancreatic acini [5]. Genistein also inhibited amylase re- 
lease stimulated by membrane-permeable cAMP-analogs, im- 
plying that genistein acts at a site distal to cAMP generation. 
The inhibition of amylase xocytosis not due to the inhibition 
of protein kinase A, since genistein scarcely inhibited the en- 
85 
zyme activity in a cell-free assay system even at 100/~g/ml (370 
/2M) [11]. In addition, those inhibitiory effects of genistein were 
specific, since daidzein inhibited neither amylase release nor 
tyrosine phosphorylation. These results suggest that genistein 
inhibits amylase xocytosis through the inhibition of protein 
tyrosine phosphorylation. 
In pancreatic acini, however, genistein markedly inhibited 
amylase release evoked by Ca, but not by phorbol ester or 
cAMP [4-6], indicating that the inhibitory effect of genistein is
strictly selective concerning secretory stimuli and cells. It is 
presently unknown why genistein is able to inhibit cAMP- 
mediated amylase release in parotid acini but not in pancreatic 
ones. From their study using pancreatic acini, Lutz et al. [4] 
suggested that the tyrosine phosphorylation pathway functions 
to amplify the secretory response rather than to provide an 
obligate signal for the secretion. It this is true, tyrosine phos- 
phorylation might amplify cAMP-mediated exocytosis instead 
of the Ca-induced one in parotid acini, where indeed cAMP- 
induced release is much more extensive than the Ca-induced 
one. Since genistein markedly inhibited major secretory path- 
ways in the two exocrine glands, the two secretory cells might 
share a common regulation (amplification) mechanism involv- 
ing tyrosine kinases. 
In the present study, for the first time, we show that iso- 
proterenol and cps-cAMP had dual effects on protein tyrosine 
phosphorylation, causing an increase in the phosphorylation f 
p190 and p210 and a decrease in that of p90. The 
dephosphorylation f p90 is not specific to cAMP, since car- 
bachol and A23187 also decreased the phosphorylation. Re- 
cently carbachol and phorbol ester were found to induce tyro- 
sine phosphorylation f protein kinase C~, although the role 
of this phosphorylation in exocytosis remains to be elucidated 
[12]. In this study, we confirmed that carbachol and PMA 
increased the phosphorylation f p80. So far the phosphoryla- 
tion ofpl90 and p210 seems to be a cAMP-specific event; and 
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Fig. 5. Effects of genistein and daidzein on protein tyrosine phosphoryl- 
ation in parotid acini. Acini were preincubated with 0, 75, 150, or 300 
pM genistein or 300 pM daidzein at 37°C for 20 min, and further 
incubated for 5 rain after addition of 1 pM isoproterenol. After incuba- 
tion, phosphotyrosine containing proteins were immunoprecipitated 
and visualized as described in Fig. 4. The results hown are from an 
experiment representative of two independent experiments. 
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hence the two proteins might be involved in the regulatory 
process of amylase xocytosis from parotid acini. However, it 
is also possible that these proteins are engaged in other cellular 
functions. For instance, chronic administration of isoprotere- 
nol into rats induces hyperplasia nd hypertrophy of parotid 
glands [13], although in our in vitro incubation system MAP 
kinase was not activated (unpublished observation). In general, 
the signaling pathway from classical second messengers, includ- 
ing cAMP, Ca, and diacylglycerol, to tyrosine kinases or tyro- 
sine phosphatases is poorly understood. Thus, further study is 
necessary to delineate the role of tyrosine phosphorylation i  
cAMP-mediated secretion and growth in parotid acinar cells. 
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